H.R. 6400 · 118th Congress

To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

Stage
In committee
Introduced
2023-11-14
Latest action
2024-12-17 · Referred to the Subcommittee on Health.

Action history

  1. 2024-12-17Referred to the Subcommittee on Health.
  2. 2023-11-17Referred to the Subcommittee on Health.
  3. 2023-11-14Introduced in House
  4. 2023-11-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. 2023-11-14Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.